Name: Prelude Therapeutics Incorporated (PRLD) Balance Sheet
Creator: FinSpry

Prelude Therapeutics Incorporated Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Prelude Therapeutics Incorporated (PRLD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	12.47	25.29	201.73	31.83	218.31
Short-Term Investments	121.14	207.64	171.12	259.41	0.00
Cash & Short-Term Investments	133.61	232.94	201.73	291.23	218.31
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.28	2.65	5.38	3.88	2.50
Total Current Assets	135.90	235.59	204.38	295.12	220.81
Non-Current Assets
Property, Plant & Equipment (Net)	35.47	37.74	6.70	5.64	2.48
Other Non-Current Assets	4.15	4.34	9.42	4.35	0.30
Total Non-Current Assets	39.62	38.03	12.08	9.98	2.48
Total Assets	175.52	277.67	220.50	305.10	223.59
Current Liabilities
Accounts Payable	7.73	4.58	19.87	7.84	3.92
Short-Term Debt	2.70	0.00	0.00	0.00	0.00
Accrued Liabilities	5.42	14.82	12.57	4.62	7.04
Other Current Liabilities	15.21	0.95	5.68	0.09	0.42
Total Current Liabilities	25.64	21.83	21.70	19.20	11.38
Non-Current Liabilities
Long-Term Debt	15.33	15.41	0.00	0.00	0.00
Other Non-Current Liabilities	3.09	3.34	3.36	0.00	0.03
Total Non-Current Liabilities	18.42	18.75	3.36	0.00	0.03
Total Liabilities	44.06	40.58	25.06	19.20	11.41
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-583.56	-456.39	-336.25	-219.12	-107.43
Accumulated Other Comprehensive Income	0.04	0.22	-1.69	-0.71	0.00
Additional Paid-in Capital	714.98	693.25	531.68	505.72	319.61
Shares Outstanding	55.15	54.91	47.90	47.60	0.00
Total Stockholders' Equity	131.46	237.09	195.44	285.90	212.18
Total Liabilities & Equity	175.52	277.67	220.50	305.10	223.59